Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men.

Courtney R, Radwanski E, Lim J, Laughlin M.

Antimicrob Agents Chemother. 2004 Mar;48(3):804-8.

2.

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.

Courtney R, Wexler D, Radwanski E, Lim J, Laughlin M.

Br J Clin Pharmacol. 2004 Feb;57(2):218-22.

4.

Comparative genetics of disease resistance within the solanaceae.

Grube RC, Radwanski ER, Jahn M.

Genetics. 2000 Jun;155(2):873-87.

5.

Genetic mapping of the Tsw locus for resistance to the Tospovirus Tomato spotted wilt virus in Capsicum spp. and its relationship to the Sw-5 gene for resistance to the same pathogen in tomato.

Jahn M, Paran I, Hoffmann K, Radwanski ER, Livingstone KD, Grube RC, Aftergoot E, Lapidot M, Moyer J.

Mol Plant Microbe Interact. 2000 Jun;13(6):673-82.

6.

Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function.

Andersen SR, Lambrecht LJ, Swan SK, Cutler DL, Radwanski E, Affrime MB, Garaud JJ.

J Clin Pharmacol. 1999 Oct;39(10):1015-20.

PMID:
10516935
7.

The penetration of ceftibuten into the respiratory tract.

Krumpe P, Lin CC, Radwanski E, Cayen MN, Affrime MB.

Chest. 1999 Aug;116(2):369-74.

PMID:
10453864
8.

Renal changes associated with naproxen sodium administration in cynomolgus monkeys.

Leach MW, Frank DW, Berardi MR, Evans EW, Johnson RC, Schuessler DG, Radwanski E, Cartwright ME.

Toxicol Pathol. 1999 May-Jun;27(3):295-306.

PMID:
10356706
9.

Effects of single intravenous doses of recombinant human interleukin-10 on subsets of circulating leukocytes in humans.

Huhn RD, Pennline K, Radwanski E, Clarke L, Sabo R, Cutler DL.

Immunopharmacology. 1999 Feb;41(2):109-17.

PMID:
10102792
10.
11.

Pharmacokinetics of flutamide in patients with renal insufficiency.

Anjum S, Swan SK, Lambrecht LJ, Radwanski E, Cutler DL, Affrime MB, Halstenson CE.

Br J Clin Pharmacol. 1999 Jan;47(1):43-7.

12.

Pharmacokinetics and leukocyte responses of recombinant human interleukin-10.

Radwanski E, Chakraborty A, Van Wart S, Huhn RD, Cutler DL, Affrime MB, Jusko WJ.

Pharm Res. 1998 Dec;15(12):1895-901.

PMID:
9892475
13.

Single-dose pharmacokinetics of isepamicin in young and geriatric volunteers.

Nomeir AA, Radwanski E, Cutler D, Affrime M, Christopher D, Korduba C, Batra V, Lin CC, Cayen MN.

J Clin Pharmacol. 1997 Nov;37(11):1021-30.

PMID:
9505995
14.
15.

Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers.

Huhn RD, Radwanski E, Gallo J, Affrime MB, Sabo R, Gonyo G, Monge A, Cutler DL.

Clin Pharmacol Ther. 1997 Aug;62(2):171-80.

PMID:
9284853
16.

Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections.

Radwanski E, Batra V, Cayen M, Korduba C, Cutler D, Affrime M, Nomeir A, Lin CC.

Antimicrob Agents Chemother. 1997 Aug;41(8):1794-6.

17.

Pharmacokinetics of intramuscularly administered isepamicin in man.

Lin CC, Radwanski E, Korduba C, Affrime M, Cayen MN.

Chemotherapy. 1997 Mar-Apr;43(2):86-93.

PMID:
9084916
18.

In-vivo/in-vitro correlation of four extended release formulations of pseudoephedrine sulfate.

Mojaverian P, Rosen J, Vadino WA, Liebowitz S, Radwanski E.

J Pharm Biomed Anal. 1997 Jan;15(4):439-45.

PMID:
8953486
19.

Characterization of tryptophan synthase alpha subunit mutants of Arabidopsis thaliana.

Radwanski ER, Barczak AJ, Last RL.

Mol Gen Genet. 1996 Dec 13;253(3):353-61.

PMID:
9003322
20.

Comparative bioavailability of ceftibuten in capsule and suspension forms.

Lin CC, Affrime M, Radwanski E, Lim J, Colucci R, Cayen MN.

Clin Ther. 1996 Nov-Dec;18(6):1139-49.

PMID:
9001830
21.

Clinical, hematologic, and immunologic effects of interleukin-10 in humans.

Fuchs AC, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Radwanski E, Affrime MB, Cutler DL, Grint PC, Dinarello CA.

J Clin Immunol. 1996 Sep;16(5):291-303.

PMID:
8886999
22.

Effect of Felbamate on The Pharmacokinetics of Clonazepam.

Colucci R, Glue P, Banfield C, Reidenberg P, Meehan J, Radwanski E, Korduba C, Lin C, Dogterom P, Ebels T, Hendriks G, Jonkman J, Affrime M.

Am J Ther. 1996 Apr;3(4):294-297.

PMID:
11862264
23.

Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers.

Huhn RD, Radwanski E, O'Connell SM, Sturgill MG, Clarke L, Cody RP, Affrime MB, Cutler DL.

Blood. 1996 Jan 15;87(2):699-705.

PMID:
8555493
24.

Pharmacokinetics and metabolism of genaconazole, a potent antifungal drug, in men.

Lin C, Kim H, Radwanski E, Affrime M, Brannan M, Cayen MN.

Antimicrob Agents Chemother. 1996 Jan;40(1):92-6.

25.

Interleukin-10 pharmacokinetics in intact and nephrectomized mice.

Chiu PJ, Radwanski E, Tetiloff G, Monge A, Swanson SJ.

Eur Cytokine Netw. 1996 Jan-Mar;7(1):67-9.

PMID:
8704097
26.

Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.

Hooper WD, Franklin ME, Glue P, Banfield CR, Radwanski E, McLaughlin DB, McIntyre ME, Dickinson RG, Eadie MJ.

Epilepsia. 1996 Jan;37(1):91-7.

PMID:
8603632
27.

Pharmacokinetics of intravenously administered isepamicin in men.

Lin CC, Radwanski E, Korduba C, Cayen M, Affrime M.

Antimicrob Agents Chemother. 1995 Dec;39(12):2774-8.

28.

Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive.

Saano V, Glue P, Banfield CR, Reidenberg P, Colucci RD, Meehan JW, Haring P, Radwanski E, Nomeir A, Lin CC, et al.

Clin Pharmacol Ther. 1995 Nov;58(5):523-31.

PMID:
7586946
29.

Arabidopsis thaliana tryptophan synthase alpha: gene cloning, expression, and subunit interaction.

Radwanski ER, Zhao J, Last RL.

Mol Gen Genet. 1995 Oct 25;248(6):657-67.

PMID:
7476868
30.

Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administration.

Lin C, Korduba C, Affrime M, Radwanski E, Nomeir A, Batra V, Cutler D, Cayen MN.

Antimicrob Agents Chemother. 1995 Oct;39(10):2201-3.

31.

Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine.

Hulsman JA, Rentmeester TW, Banfield CR, Reidenberg P, Colucci RD, Meehan JW, Radwanski E, Mojaverian P, Lin CC, Nezamis J, et al.

Clin Pharmacol Ther. 1995 Oct;58(4):383-9.

PMID:
7586929
32.

Comment: pharmacokinetic variability of aminoglycosides.

Colucci RD, Glue P, Banfield CR, Radwanski E.

Ann Pharmacother. 1995 Sep;29(9):939-40. No abstract available.

PMID:
8547752
33.

Effects of felbamate on the pharmacokinetics of phenobarbital.

Reidenberg P, Glue P, Banfield CR, Colucci RD, Meehan JW, Radwanski E, Mojavarian P, Lin CC, Nezamis J, Guillaume M, et al.

Clin Pharmacol Ther. 1995 Sep;58(3):279-87.

PMID:
7554701
34.

Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations.

Brannan MD, Reidenberg P, Radwanski E, Shneyer L, Lin CC, Cayen MN, Affrime MB.

Clin Pharmacol Ther. 1995 Sep;58(3):269-78.

PMID:
7554700
35.

Pharmacokinetic interaction studies between felbamate and vigabatrin.

Reidenberg P, Glue P, Banfield C, Colucci R, Meehan J, Rey E, Radwanski E, Nomeir A, Lim J, Lin C, et al.

Br J Clin Pharmacol. 1995 Aug;40(2):157-60.

36.

Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).

Oosterhuis B, Brannan MD, Groen H, Peeters PA, Hempenius J, Radwanski E, Nomeir AA, Affrime MB, Jonkman JH.

Ann Allergy Asthma Immunol. 1995 Aug;75(2):157-61.

PMID:
7648380
37.

Pharmacokinetics of Loratadine in Pediatric Subjects.

Lin CC, Radwanski E, Affrime M, Cayen M.

Am J Ther. 1995 Jul;2(7):504-508.

PMID:
11850699
38.

Comparison of 4- and 24-hour intravenous infusion schedules for granulocyte-macrophage colony-stimulating factor.

Wong L, Taylor CW, Radwanski E, Hersh EM, Salmon SE.

J Immunother Emphasis Tumor Immunol. 1995 Jul;18(1):57-65. No abstract available.

PMID:
8535572
39.

Tryptophan biosynthesis and metabolism: biochemical and molecular genetics.

Radwanski ER, Last RL.

Plant Cell. 1995 Jul;7(7):921-34. Review. No abstract available.

40.

Pharmacokinetics of isepamicin in paediatric patients.

Scaglione F, ViganĂ² A, Colucci R, Zampaglione N, Lin CC, Cutler D, Guerciolini R, Elliott M, Affrime M, Radwanski E.

J Chemother. 1995 Jun;7 Suppl 2:63-9.

PMID:
8622112
41.

Pharmacokinetics of isepamicin.

Barr WH, Colucci R, Radwanski E, Zampaglione N, Cutler D, Lin CC, Elliott M, Affrime MB.

J Chemother. 1995 Jun;7 Suppl 2:53-61. Review.

PMID:
8622111
42.

Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation.

Kosoglou T, Patrick JE, Cohen A, Radwanski E, Christopher D, Affrime MB.

Clin Ther. 1995 Mar-Apr;17(2):241-51.

PMID:
7614524
43.

Effect of food on the oral bioavailability of isosorbide-5-mononitrate administered as an extended-release tablet.

Kosoglou T, Kazierad DJ, Schentag JJ, Patrick JE, Heimark L, Radwanski E, Christopher D, Flannery BE, Affrime MB.

J Clin Pharmacol. 1995 Feb;35(2):151-8.

PMID:
7751425
44.

Pharmacokinetics and dose proportionality of ceftibuten in men.

Lin C, Lim J, Radwanski E, Marco A, Affrime M.

Antimicrob Agents Chemother. 1995 Feb;39(2):359-61.

45.

Multiple-dose pharmacokinetics of ceftibuten in healthy volunteers.

Lin C, Radwanski E, Affrime M, Cayen MN.

Antimicrob Agents Chemother. 1995 Feb;39(2):356-8.

46.

Pharmacokinetics of the triazole antifungal agent genaconazole in healthy men after oral and intravenous administration.

Mojaverian P, Radwanski E, Affrime MB, Cayen MN, Lin CC.

Antimicrob Agents Chemother. 1994 Dec;38(12):2758-62.

47.

Multiple-Dose Pharmacokinetics of Ceftibuten in Healthy Adults and Geriatric Volunteers.

Radwanski E, Teal M, Affrime M, Cayen M, Lin CC.

Am J Ther. 1994 Jun;1(1):42-48.

PMID:
11835066
48.

Differential plasma duration of antiplatelet-activating factor and antihistamine activities of oral Sch 37370 in humans.

Billah MM, Gilchrest HG, Eckel SP, Granzow CA, Lawton PJ, Radwanski E, Brannan MD, Affrime MB, Christopher JD, Richards W, et al.

Clin Pharmacol Ther. 1992 Aug;52(2):151-9.

PMID:
1505150
49.

Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulations.

Mojaverian P, Radwanski E, Lin CC, Cho P, Vadino WA, Rosen JM.

Pharm Res. 1992 Apr;9(4):450-6.

PMID:
1495888
50.

Tryptophan mutants in Arabidopsis: the consequences of duplicated tryptophan synthase beta genes.

Last RL, Bissinger PH, Mahoney DJ, Radwanski ER, Fink GR.

Plant Cell. 1991 Apr;3(4):345-58.

Supplemental Content

Loading ...
Support Center